僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Milatuzumab （hLL1; MEDI-115） is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death